These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38298309)
1. Underprescription of Fibrate Among Patients With Diabetic Retinopathy in Perak, Malaysia. Jamaluddin J; Mohamed Kamel MA Cureus; 2024 Jan; 16(1):e51434. PubMed ID: 38298309 [TBL] [Abstract][Full Text] [Related]
2. New fibrate use and acute renal outcomes in elderly adults: a population-based study. Zhao YY; Weir MA; Manno M; Cordy P; Gomes T; Hackam DG; Juurlink DN; Mamdani M; Moist L; Parikh CR; Paterson JM; Wald R; Yao Z; Garg AX Ann Intern Med; 2012 Apr; 156(8):560-9. PubMed ID: 22508733 [TBL] [Abstract][Full Text] [Related]
3. Diabetic retinopathy among type 2 diabetes mellitus patients in Sabah primary health clinics-Addressing the underlying factors. Naserrudin NA; Jeffree MS; Kaur N; Syed Abdul Rahim SS; Ibrahim MY PLoS One; 2022; 17(1):e0261249. PubMed ID: 35089931 [TBL] [Abstract][Full Text] [Related]
4. Statins and/or fibrates for diabetic retinopathy: a systematic review and meta-analysis. Mozetic V; Pacheco RL; Latorraca COC; Riera R Diabetol Metab Syndr; 2019; 11():92. PubMed ID: 31719846 [TBL] [Abstract][Full Text] [Related]
5. [Effects of Fibrates on Risk of Development of Diabetic Retinopathy in Japanese Working Age Patients with Type 2 Diabetes and Dyslipidemia: a Retrospective Cohort Study]. Akimoto H; Takahashi Y; Asai S Yakugaku Zasshi; 2021; 141(5):761-769. PubMed ID: 33952760 [TBL] [Abstract][Full Text] [Related]
6. Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study. Ho WY; Yen CL; Lee CC; Tu YR; Chen CY; Hsiao CC; Chu PH; Hsu HH; Tian YC; Chang CH Front Cardiovasc Med; 2022; 9():907539. PubMed ID: 36440016 [TBL] [Abstract][Full Text] [Related]
7. Use of fibrates in the United States and Canada. Jackevicius CA; Tu JV; Ross JS; Ko DT; Carreon D; Krumholz HM JAMA; 2011 Mar; 305(12):1217-24. PubMed ID: 21427374 [TBL] [Abstract][Full Text] [Related]
8. Physician variation in the de-adoption of ineffective statin and fibrate therapy. Everhart A; Desai NR; Dowd B; Herrin J; Higuera L; Jeffery MM; Jena AB; Ross JS; Shah ND; Smith LB; Karaca-Mandic P Health Serv Res; 2021 Oct; 56(5):919-931. PubMed ID: 33569804 [TBL] [Abstract][Full Text] [Related]
9. Five-year trend in secondary prevention medication prescription and risk factor control among patients with diabetes mellitus and cardiovascular diseases in Perak health clinics. Jamaluddin J; Mohamed-Kamel MA; Din NSS; Mohamad-Isa MZ Malays Fam Physician; 2024; 19():46. PubMed ID: 39156231 [TBL] [Abstract][Full Text] [Related]
10. Do persons with diabetes benefit from combination statin and fibrate therapy? Rosenblit PD Curr Cardiol Rep; 2012 Feb; 14(1):112-24. PubMed ID: 22213157 [TBL] [Abstract][Full Text] [Related]
11. Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study. Morgan CL; Owens DR; Aubonnet P; Carr ES; Jenkins-Jones S; Poole CD; Currie CJ BMJ Open; 2013 Dec; 3(12):e004025. PubMed ID: 24302508 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Diabetic Retinopathy and Risk Factors among Diabetic Patients at University of Gondar Tertiary Eye Care and Training Center, North-West Ethiopia. Ejigu T; Tsegaw A Middle East Afr J Ophthalmol; 2021; 28(2):71-80. PubMed ID: 34759663 [TBL] [Abstract][Full Text] [Related]
13. Use of Fibrates Monotherapy in People with Diabetes and High Cardiovascular Risk in Primary Care: A French Nationwide Cohort Study Based on National Administrative Databases. Roussel R; Chaignot C; Weill A; Travert F; Hansel B; Marre M; Ricordeau P; Alla F; Allemand H PLoS One; 2015; 10(9):e0137733. PubMed ID: 26398765 [TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias. Suh HS; Hay JW; Johnson KA; Doctor JN Pharmacoepidemiol Drug Saf; 2012 May; 21(5):470-84. PubMed ID: 22461130 [TBL] [Abstract][Full Text] [Related]
15. Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review. Mozetic V; Freitas CG; Riera R JMIR Res Protoc; 2017 Feb; 6(2):e30. PubMed ID: 28228373 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of fibrate-statin combination therapy compared to fibrate monotherapy in patients with dyslipidemia: a meta-analysis. Choi HD; Shin WG; Lee JY; Kang BC Vascul Pharmacol; 2015; 65-66():23-30. PubMed ID: 25451563 [TBL] [Abstract][Full Text] [Related]
17. Hyperlipidaemia and cardiovascular disease: do fibrates have a role? Saha SA; Arora RR Curr Opin Lipidol; 2011 Aug; 22(4):270-6. PubMed ID: 21519250 [TBL] [Abstract][Full Text] [Related]
18. Comparison of pleiotropic effects of statins vs fibrates on laboratory parameters in patients with dyslipidemia: A retrospective cohort study. Takeuchi S; Takahashi Y; Asai S Medicine (Baltimore); 2020 Dec; 99(50):e23427. PubMed ID: 33327270 [TBL] [Abstract][Full Text] [Related]
19. Pharmacoepidemiology safety study of fibrate and statin concomitant therapy. Enger C; Gately R; Ming EE; Niemcryk SJ; Williams L; McAfee AT Am J Cardiol; 2010 Dec; 106(11):1594-601. PubMed ID: 21094360 [TBL] [Abstract][Full Text] [Related]
20. Serum lipid comparison in patients treated by statins or fibrates: existence of bad HDL-C responders to statins. Devroey D; Velkeniers B; Duquet W; Betz W Acta Cardiol; 2003 Jun; 58(3):179-84. PubMed ID: 12846506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]